Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Yao-Shen Chen, MD

Investigator
Kaohsiung Veterans General Hospital

Disclosure(s): No financial relationships to disclose

Poster(s):

(P-792) Evaluation of the efficacy and safety of a short-course, daily, 4-month regimen including isoniazid, pyrazinamide, rifapentine and moxifloxacin (2HZPM/2HPM) for the treatment of drug-susceptible pulmonary tuberculosis in Taiwan (ESCAPE-TB): A multicenter study

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-2026) Obeldesivir for the Treatment of COVID-19 in People with Risk Factors for Progression to Severe Disease: the BIRCH Study

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT